Form 10-Q · Quarterly report
International Flavors & Fragrances 10-Q, filed Aug 4, 2026
- Filed
- CIK
- 0000051253
- Accession no.
- 0000051253-26-000030
Summary
International Flavors & Fragrances reported second-quarter 2026 net sales of 1.954 billion, up 2% on a reported basis and 6% on a comparable currency-neutral basis, while net income from continuing operations fell 94% to 33 million. On May 29, 2026, IFF announced a definitive agreement to divest its Food Ingredients disposal group and classified Food Ingredients and SCL as discontinued operations.
Key points
- Second-quarter 2026 net sales rose 2% to 1.954 billion from 1.919 billion a year earlier, and comparable currency-neutral sales rose 6%.
- Gross profit rose 4% to 853 million, or 43.7% of sales, helped by volume increases, productivity gains, and tariff refunds.
- Net income from continuing operations fell 94% to 33 million, and net income attributable to IFF shareholders was 50 million, down 92% from 599 million.
- IFF completed the divestitures of Pharma Solutions on May 1, 2025, and Nitrocellulose on May 9, 2025.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION OVERVIEW Company Background We are organized into three reportable operating segments: Taste, Health & Biosciences, and Scent. Our Taste segment consists of the development and production of a range of flavor compounds and natural taste solutions that are ultimately used by our customers in a diverse variety of products, including savory products (soups, sauces, meat, fish, poultry, snacks, etc.), beverages (juice drinks, carbonated or flavored beverages, spirits, etc.), sweets (bakery products, candy, cereal, chewing gum, etc.), and dairy products (yogurt, ice cream, cheese, etc.). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.